Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mayersohn

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|May 1, 1987
Effect of azotemia in dogs on the pharmacokinetics of pentamidineT R Navin, C M Dickinson, S R Adams, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Digoxin-diltiazem interaction: a pharmacokinetic evaluationW N Jones, K B Kern, J P Rindone, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1980
Metabolism and rate of elimination of digoxigenin bisdigitoxoside in dogs before and during chronic azotemiaK D Gierke, P E Graves, D Perrier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 5, 1999
Human moricizine metabolism. II. Quantification and pharmacokinetics of plasma and urinary metabolitesH J Pieniaszek, A F Davidson, J E Chaney, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Bleomycin pharmacokinetics in man. II. Intracavitary administrationD S Alberts, H S Chen, M Mayersohn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 miceJ M Sauer, J Bao, R L Smith, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of the aldose reductase inhibitor tolrestat: studies in healthy young and elderly male and female subjects and in subjects with diabetesR Fruncillo, S Troy, V Parker, et al.
The American Journal of Cardiology|November 1, 1980
Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparationE G Giardina, P E Fenster, J T Bigger, et al.
The New England Journal of Medicine|May 31, 1979
Digoxin-quinidine interaction Pharmacokinetic evaluationW D Hager, P Fenster, M Mayersohn, et al.
Circulation|December 1, 1978
Relationship between plasma concentration and dose of digoxin in patients with and without renal impairmentR D Okada, W D Hager, P E Graves, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|May 1, 1987
Effect of azotemia in dogs on the pharmacokinetics of pentamidineT R Navin, C M Dickinson, S R Adams, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Digoxin-diltiazem interaction: a pharmacokinetic evaluationW N Jones, K B Kern, J P Rindone, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1980
Metabolism and rate of elimination of digoxigenin bisdigitoxoside in dogs before and during chronic azotemiaK D Gierke, P E Graves, D Perrier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 5, 1999
Human moricizine metabolism. II. Quantification and pharmacokinetics of plasma and urinary metabolitesH J Pieniaszek, A F Davidson, J E Chaney, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Bleomycin pharmacokinetics in man. II. Intracavitary administrationD S Alberts, H S Chen, M Mayersohn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 miceJ M Sauer, J Bao, R L Smith, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of the aldose reductase inhibitor tolrestat: studies in healthy young and elderly male and female subjects and in subjects with diabetesR Fruncillo, S Troy, V Parker, et al.
The American Journal of Cardiology|November 1, 1980
Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparationE G Giardina, P E Fenster, J T Bigger, et al.
The New England Journal of Medicine|May 31, 1979
Digoxin-quinidine interaction Pharmacokinetic evaluationW D Hager, P Fenster, M Mayersohn, et al.
Circulation|December 1, 1978
Relationship between plasma concentration and dose of digoxin in patients with and without renal impairmentR D Okada, W D Hager, P E Graves, et al.
Pageof 13